Owkin
operating company · company profileParis · 1 people tracked
Find your way into Owkin
509 people in our graph share verified history with the Owkin team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Owkin is an AI company building an autonomous AI Scientist to automate biopharmaceutical R&D and support clinical research, powered by a multimodal patient data network and wet lab validation.
Source: firm website, verified Sep 26, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1Biotech ×1Digital Health ×1Healthtech ×1
HQs:France×1
Investments · 1 tracked
founders shown can be your intro pathBioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation.
AI & Machine LearningBiotechDigital HealthHealthtechParis, FR
Eric Durand(Founder)inFelipe Llinares-López(Co-founder & VP of AI)inRodolphe Jenatton(Co-founder & CTO)inZelda Mariet(Co-founder & VP of Research)inJean-Philippe Vert(Co-founder & CEO)inDavid Cahané(Co-founder & General Manager)
PartnerThomas Clozel· solo GP
Co-investorsAndera PartnersCathay InnovationFELIX CAPITALFrstHeadlineHeadline Growth Management, LLC+6 more
Frequently asked questions
- What sectors does Owkin focus on?
- Owkin focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech.
- Where is Owkin located?
- Owkin is headquartered in Paris, FR.
Media · Podcasts & interviews
featuring the teamDr. Thomas Clozel, Co‑Founder & CEO of Owkin | FII 2025 Interview
Ian Khan "The Futurist" · Thomas Clozel
Thomas Clozel, Owkin | What does Ai Biotech really mean | E10
FlotBio x Philip Hemme · Thomas Clozel
The Owkin Podcast | Ullrich Keilholtz
Owkin
Owkin x Super Human | Jon Levy
Owkin
Owkin Podcast | Antoine Yver
Owkin
Superhuman Summit Keynote | Thomas Clozel
Owkin















